Emergence of antimicrobial resistance to Pseudomonas aeruginosa in the intensive care unit: association with the duration of antibiotic exposure and mode of administration

Abstract Background Antibiotics are frequently used in intensive care units (ICUs), and their use is associated with the emergence of bacterial resistance to antibiotics. The aim of this study was to investigate the association between the emergence of Pseudomonas aeruginosa resistance and the durat...

Full description

Bibliographic Details
Main Authors: Erlangga Yusuf, Bruno Van Herendael, Walter Verbrugghe, Margareta Ieven, Emiel Goovaerts, Kristof Bergs, Kristien Wouters, Philippe G. Jorens, Herman Goossens
Format: Article
Language:English
Published: SpringerOpen 2017-06-01
Series:Annals of Intensive Care
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13613-017-0296-z
_version_ 1830140841390243840
author Erlangga Yusuf
Bruno Van Herendael
Walter Verbrugghe
Margareta Ieven
Emiel Goovaerts
Kristof Bergs
Kristien Wouters
Philippe G. Jorens
Herman Goossens
author_facet Erlangga Yusuf
Bruno Van Herendael
Walter Verbrugghe
Margareta Ieven
Emiel Goovaerts
Kristof Bergs
Kristien Wouters
Philippe G. Jorens
Herman Goossens
author_sort Erlangga Yusuf
collection DOAJ
description Abstract Background Antibiotics are frequently used in intensive care units (ICUs), and their use is associated with the emergence of bacterial resistance to antibiotics. The aim of this study was to investigate the association between the emergence of Pseudomonas aeruginosa resistance and the duration of antibiotic exposure or mode of administration in an ICU unit. Methods A 4-year cohort study of intensive care unit was performed in patients with P. aeruginosa isolates from clinical specimens, initially susceptible to the investigated antibiotics (piperacillin/tazobactam, ceftazidime, ciprofloxacin, meropenem and amikacin). Odds ratios (ORs) with 95% confidence interval (95% CI) of emergence of resistance were calculated using logistic regression analysis for various exposure periods to antibiotics (1–3, 4–7, 8–15 and >15 days) relative to no exposure with adjustment for age, sex, Simplified Acute Physiology Score 3 (SAPS 3) and length of stay. ORs on the emergence of P. aeruginosa resistance were also calculated for the various modes of administration. Results Included were 187 patients [mean age 61 years, 69% male, mean SAPS 3 score (SD): 59 (12.3)]. None of the antibiotics investigated showed the emergence of resistance within 1–3 days. Significant meropenem resistance emerged within 8–15 days [OR 79.1 (14.9–421.0)] after antibiotic exposure unlike other antibiotics (>15 days). No difference was observed between intermittent and extended administration of meropenem and between beta-lactam mono- or combined therapy. Conclusions Use of meropenem was associated with the emergence of resistance as soon as 8 days after exposure to the antibiotic.
first_indexed 2024-12-17T09:10:09Z
format Article
id doaj.art-73bab00cd70f429f9f3795635c8f8bb9
institution Directory Open Access Journal
issn 2110-5820
language English
last_indexed 2024-12-17T09:10:09Z
publishDate 2017-06-01
publisher SpringerOpen
record_format Article
series Annals of Intensive Care
spelling doaj.art-73bab00cd70f429f9f3795635c8f8bb92022-12-21T21:55:15ZengSpringerOpenAnnals of Intensive Care2110-58202017-06-01711710.1186/s13613-017-0296-zEmergence of antimicrobial resistance to Pseudomonas aeruginosa in the intensive care unit: association with the duration of antibiotic exposure and mode of administrationErlangga Yusuf0Bruno Van Herendael1Walter Verbrugghe2Margareta Ieven3Emiel Goovaerts4Kristof Bergs5Kristien Wouters6Philippe G. Jorens7Herman Goossens8Department of Microbiology, Antwerp University Hospital (UZA), University of AntwerpDepartment of Microbiology, Antwerp University Hospital (UZA), University of AntwerpDepartment of Intensive Care Medicine, Antwerp University Hospital (UZA), University of AntwerpDepartment of Microbiology, Antwerp University Hospital (UZA), University of AntwerpDepartment of Hospital Hygiene and Infection Control, Antwerp University Hospital (UZA), University of AntwerpDepartment of Intensive Care Medicine, Antwerp University Hospital (UZA), University of AntwerpDepartment of Biostatistics, Antwerp University Hospital (UZA), University of AntwerpDepartment of Intensive Care Medicine, Antwerp University Hospital (UZA), University of AntwerpDepartment of Microbiology, Antwerp University Hospital (UZA), University of AntwerpAbstract Background Antibiotics are frequently used in intensive care units (ICUs), and their use is associated with the emergence of bacterial resistance to antibiotics. The aim of this study was to investigate the association between the emergence of Pseudomonas aeruginosa resistance and the duration of antibiotic exposure or mode of administration in an ICU unit. Methods A 4-year cohort study of intensive care unit was performed in patients with P. aeruginosa isolates from clinical specimens, initially susceptible to the investigated antibiotics (piperacillin/tazobactam, ceftazidime, ciprofloxacin, meropenem and amikacin). Odds ratios (ORs) with 95% confidence interval (95% CI) of emergence of resistance were calculated using logistic regression analysis for various exposure periods to antibiotics (1–3, 4–7, 8–15 and >15 days) relative to no exposure with adjustment for age, sex, Simplified Acute Physiology Score 3 (SAPS 3) and length of stay. ORs on the emergence of P. aeruginosa resistance were also calculated for the various modes of administration. Results Included were 187 patients [mean age 61 years, 69% male, mean SAPS 3 score (SD): 59 (12.3)]. None of the antibiotics investigated showed the emergence of resistance within 1–3 days. Significant meropenem resistance emerged within 8–15 days [OR 79.1 (14.9–421.0)] after antibiotic exposure unlike other antibiotics (>15 days). No difference was observed between intermittent and extended administration of meropenem and between beta-lactam mono- or combined therapy. Conclusions Use of meropenem was associated with the emergence of resistance as soon as 8 days after exposure to the antibiotic.http://link.springer.com/article/10.1186/s13613-017-0296-zPseudomonas aeruginosaAntibiotic resistanceExtended infusion
spellingShingle Erlangga Yusuf
Bruno Van Herendael
Walter Verbrugghe
Margareta Ieven
Emiel Goovaerts
Kristof Bergs
Kristien Wouters
Philippe G. Jorens
Herman Goossens
Emergence of antimicrobial resistance to Pseudomonas aeruginosa in the intensive care unit: association with the duration of antibiotic exposure and mode of administration
Annals of Intensive Care
Pseudomonas aeruginosa
Antibiotic resistance
Extended infusion
title Emergence of antimicrobial resistance to Pseudomonas aeruginosa in the intensive care unit: association with the duration of antibiotic exposure and mode of administration
title_full Emergence of antimicrobial resistance to Pseudomonas aeruginosa in the intensive care unit: association with the duration of antibiotic exposure and mode of administration
title_fullStr Emergence of antimicrobial resistance to Pseudomonas aeruginosa in the intensive care unit: association with the duration of antibiotic exposure and mode of administration
title_full_unstemmed Emergence of antimicrobial resistance to Pseudomonas aeruginosa in the intensive care unit: association with the duration of antibiotic exposure and mode of administration
title_short Emergence of antimicrobial resistance to Pseudomonas aeruginosa in the intensive care unit: association with the duration of antibiotic exposure and mode of administration
title_sort emergence of antimicrobial resistance to pseudomonas aeruginosa in the intensive care unit association with the duration of antibiotic exposure and mode of administration
topic Pseudomonas aeruginosa
Antibiotic resistance
Extended infusion
url http://link.springer.com/article/10.1186/s13613-017-0296-z
work_keys_str_mv AT erlanggayusuf emergenceofantimicrobialresistancetopseudomonasaeruginosaintheintensivecareunitassociationwiththedurationofantibioticexposureandmodeofadministration
AT brunovanherendael emergenceofantimicrobialresistancetopseudomonasaeruginosaintheintensivecareunitassociationwiththedurationofantibioticexposureandmodeofadministration
AT walterverbrugghe emergenceofantimicrobialresistancetopseudomonasaeruginosaintheintensivecareunitassociationwiththedurationofantibioticexposureandmodeofadministration
AT margaretaieven emergenceofantimicrobialresistancetopseudomonasaeruginosaintheintensivecareunitassociationwiththedurationofantibioticexposureandmodeofadministration
AT emielgoovaerts emergenceofantimicrobialresistancetopseudomonasaeruginosaintheintensivecareunitassociationwiththedurationofantibioticexposureandmodeofadministration
AT kristofbergs emergenceofantimicrobialresistancetopseudomonasaeruginosaintheintensivecareunitassociationwiththedurationofantibioticexposureandmodeofadministration
AT kristienwouters emergenceofantimicrobialresistancetopseudomonasaeruginosaintheintensivecareunitassociationwiththedurationofantibioticexposureandmodeofadministration
AT philippegjorens emergenceofantimicrobialresistancetopseudomonasaeruginosaintheintensivecareunitassociationwiththedurationofantibioticexposureandmodeofadministration
AT hermangoossens emergenceofantimicrobialresistancetopseudomonasaeruginosaintheintensivecareunitassociationwiththedurationofantibioticexposureandmodeofadministration